{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:08:36Z","timestamp":1793315316063,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Education, Science and Universities, Spain","award":["FPU Contract"],"award-info":[{"award-number":["FPU Contract"]}]},{"name":"Fundaci\u00f3n S\u00e9neca-CARM","award":["20786\/PI\/18"],"award-info":[{"award-number":["20786\/PI\/18"]}]},{"name":"Fundaci\u00f3n S\u00e9neca-CARM","award":["20786\/PI\/18"],"award-info":[{"award-number":["20786\/PI\/18"]}]},{"name":"Fundaci\u00f3n S\u00e9neca-CARM","award":["20786\/PI\/18"],"award-info":[{"award-number":["20786\/PI\/18"]}]},{"name":"Ministry of Education, Science, and Universities of Spain","award":["RTI2018-094393-B-C21"],"award-info":[{"award-number":["RTI2018-094393-B-C21"]}]},{"name":"Ministry of Education, Science, and Universities of Spain","award":["RTI2018-094393-B-C21"],"award-info":[{"award-number":["RTI2018-094393-B-C21"]}]},{"name":"Ministry of Education, Science, and Universities of Spain","award":["RTI2018-094393-B-C21"],"award-info":[{"award-number":["RTI2018-094393-B-C21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02653-1","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T05:15:05Z","timestamp":1769663705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of p38 MAPK in the cytokine reprogramming of a human leukemic cell line with a drug-resistant phenotype"],"prefix":"10.1186","volume":"24","author":[{"given":"Paula","family":"Cadenas-Garrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azahara M","family":"Garc\u00eda-Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Parrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Herrera-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"de Diego Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Saceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pelegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Sacramento","family":"D\u00edaz-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mart\u00edn-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2653_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fmolb.2020.00063","volume":"7","author":"JP Vernot","year":"2020","unstructured":"Vernot JP. Senescence-Associated Pro-inflammatory cytokines and tumor cell plasticity. Front Mol Biosci. 2020;7:63. https:\/\/doi.org\/10.3389\/fmolb.2020.00063.","journal-title":"Front Mol Biosci"},{"key":"2653_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","volume":"21","author":"P Nallasamy","year":"2022","unstructured":"Nallasamy P, Nimmakayala RK, Parte S, Are AC, Batra SK, Ponnusamy MP. Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Mol Cancer. 2022;21:225. https:\/\/doi.org\/10.1186\/s12943-022-01682-x.","journal-title":"Mol Cancer"},{"key":"2653_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.semcancer.2021.09.003","volume":"85","author":"S Mukhopadhyay","year":"2022","unstructured":"Mukhopadhyay S, Mahapatra KK, Praharaj PP, Patil S, Bhutia SK. Recent progress of autophagy signaling in tumor microenvironment and its targeting for possible cancer therapeutics. Sem Cancer Biol. 2022;85:196\u2013208. https:\/\/doi.org\/10.1016\/j.semcancer.2021.09.003.","journal-title":"Sem Cancer Biol"},{"key":"2653_CR4","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.drup.2022.100905","volume":"66","author":"J Fan","year":"2023","unstructured":"Fan J, To KKW, Chen Z-S, Fu L. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance. Drug Resist Updat. 2023;66:100905. https:\/\/doi.org\/10.1016\/j.drup.2022.100905.","journal-title":"Drug Resist Updat"},{"key":"2653_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbcan.2016.03.005","volume":"1865","author":"VS Jones","year":"2016","unstructured":"Jones VS, Huang R-Y, Chen L-P, Chen Z-S, Fu L, Huang R-P. Cytokines in cancer drug resistance: cues to new therapeutic strategies. Biochim Biophys Acta. 2016;1865:255\u201365. https:\/\/doi.org\/10.1016\/j.bbcan.2016.03.005.","journal-title":"Biochim Biophys Acta"},{"key":"2653_CR6","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","volume":"41","author":"S Kudaravalli","year":"2022","unstructured":"Kudaravalli S, den Hollander P, Mani SA. Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene. 2022;41:3177\u201385. https:\/\/doi.org\/10.1038\/s41388-022-02329-3.","journal-title":"Oncogene"},{"key":"2653_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/ni.1640","volume":"9","author":"C Kim","year":"2008","unstructured":"Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, Lawrence T, Otsu K, Brissette JL, Arthur JSC, Park JM. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol. 2008;9:1019\u201327. https:\/\/doi.org\/10.1038\/ni.1640.","journal-title":"Nat Immunol"},{"key":"2653_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.4049\/jimmunol.1202683","volume":"190","author":"K Katholnig","year":"2013","unstructured":"Katholnig K, Kaltenecker CC, Hayakawa H, Rosner M, Lassnig C, Zlabinger GJ, Gaestel M, M\u00fcller M, Hengstschl\u00e4ger M, H\u00f6rl WH, Park JM, S\u00e4emann MD. Weichhart, p38\u03b1 senses environmental stress to control innate immune responses via mechanistic target of Rapamycin. J Immunol. 2013;190:1519\u201327. https:\/\/doi.org\/10.4049\/jimmunol.1202683.","journal-title":"J Immunol"},{"key":"2653_CR9","doi-asserted-by":"publisher","first-page":"e0183662","DOI":"10.1371\/journal.pone.0183662","volume":"12","author":"DW Edwardson","year":"2017","unstructured":"Edwardson DW, Boudreau J, Mapletoft J, Lanner C, Kovala AT, Parissenti AM. Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance. PLoS ONE. 2017;12:e0183662. https:\/\/doi.org\/10.1371\/journal.pone.0183662.","journal-title":"PLoS ONE"},{"key":"2653_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood.V60.6.1305.1305","volume":"60","author":"HW Findley","year":"1982","unstructured":"Findley HW, Cooper MD, Kim TH, Alvarado C, Ragab AH. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood. 1982;60:1305\u20139.","journal-title":"Blood"},{"key":"2653_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yexcr.2014.11.017","volume":"331","author":"D Cerezo","year":"2015","unstructured":"Cerezo D, C\u00e1novas M, Garc\u00eda-Pe\u00f1arrubia P, Mart\u00edn-Orozco E. Collateral sensitivity to cold stress and differential BCL-2 family expression in new daunomycin-resistant lymphoblastoid cell lines. Exp Cell Res. 2015;331:11\u201320. https:\/\/doi.org\/10.1016\/j.yexcr.2014.11.017.","journal-title":"Exp Cell Res"},{"key":"2653_CR12","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1073\/pnas.85.12.4486","volume":"85","author":"I Pastan","year":"1988","unstructured":"Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci U S A. 1988;85:4486\u201390. https:\/\/doi.org\/10.1073\/pnas.85.12.4486.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2653_CR13","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/jcb.24016","volume":"113","author":"D Cerezo","year":"2012","unstructured":"Cerezo D, Lencina M, Ruiz-Alcaraz AJ, Ferragut JA, Saceda M, Sanchez M, C\u00e1novas M, Garc\u00eda-Pe\u00f1arrubia P, Mart\u00edn-Orozco E. Acquisition of MDR phenotype by leukemic cells is associated with increased caspase-3 activity and a collateral sensitivity to cold stress. J Cell Biochem. 2012;113:1416\u201325. https:\/\/doi.org\/10.1002\/jcb.24016.","journal-title":"J Cell Biochem"},{"key":"2653_CR14","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1158\/1535-7163.MCT-09-0293","volume":"8","author":"SM Mumenthaler","year":"2009","unstructured":"Mumenthaler SM, Ng PYB, Hodge A, Bearss D, Berk G, Kanekal S, Redkar S, Taverna P, Agus DB, Jain A. Pharmacologic Inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Mol Cancer Ther. 2009;8:2882\u201393. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0293.","journal-title":"Mol Cancer Ther"},{"key":"2653_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3892\/ol.2020.12042","volume":"20","author":"X Gong","year":"2020","unstructured":"Gong X, Wang B, Yan L, Lu X, Zhao X. Linalool inhibits the growth of human T cell acute lymphoblastic leukemia cells with involvement of the MAPK signaling pathway. Oncol Lett. 2020;20:181. https:\/\/doi.org\/10.3892\/ol.2020.12042.","journal-title":"Oncol Lett"},{"key":"2653_CR16","doi-asserted-by":"publisher","first-page":"e0266472","DOI":"10.1371\/journal.pone.0266472","volume":"17","author":"V Kothari","year":"2022","unstructured":"Kothari V, Babu JR, Mathews ST. AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C\/EBP\u03b2\/E3 ubiquitin ligase signaling pathway. PLoS ONE. 2022;17:e0266472. https:\/\/doi.org\/10.1371\/journal.pone.0266472.","journal-title":"PLoS ONE"},{"key":"2653_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y, Xu H, Xie X, Liu S, Jiang X, Wang M, Tang Q, Zhang J, Yang R, Fan Z, Lyu H, Lin J, Li K, Lee M-H. FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduct Target Ther. 2023;8:187. https:\/\/doi.org\/10.1038\/s41392-023-01405-8.","journal-title":"Signal Transduct Target Ther"},{"key":"2653_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41390-022-02153-1","volume":"93","author":"AM Garcia-Serna","year":"2023","unstructured":"Garcia-Serna AM, Morales E, Cantero-Cano E, Norte-Mu\u00f1oz M, Gil-Buend\u00eda MA, Velazquez-Marin J, Hernandez-Caselles T, Perez-Fernandez V, Martinez-Torres AE, Garcia-Marcos L, Martin-Orozco E. NELA study Group, cytokine production by newborns: influence of sex and season of birth. Pediatr Res. 2023;93:526\u201334. https:\/\/doi.org\/10.1038\/s41390-022-02153-1.","journal-title":"Pediatr Res"},{"key":"2653_CR19","unstructured":"Zhang X, Yashiro M, Qiu H, Nishii T,Matsuzaki T, Hirakawa K. Establishment and characterization of multidrug-resistant gastriccancer cell lines. Anticancer Res. 2010;30:915\u201321."},{"key":"2653_CR20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1158\/2159-8290.CD-20-1265","volume":"12","author":"CA Chang","year":"2022","unstructured":"Chang CA, Jen J, Jiang S, Sayad A, Mer AS, Brown KR, Nixon AML, Dhabaria A, Tang KH, Venet D, Sotiriou C, Deng J, Wong K-K, Adams S, Meyn P, Heguy A, Skok JA, Tsirigos A, Ueberheide B, Moffat J, Singh A, Haibe-Kains B, Khodadadi-Jamayran A, Neel BG. Ontogeny and vulnerabilities of Drug-Tolerant persisters in HER2\u2009+\u2009Breast cancer. Cancer Discov. 2022;12:1022\u201345. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1265.","journal-title":"Cancer Discov"},{"key":"2653_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","volume":"9","author":"J He","year":"2024","unstructured":"He J, Qiu Z, Fan J, Xie X, Sheng Q, Sui X. Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies. Sig Transduct Target Ther. 2024;9:209. https:\/\/doi.org\/10.1038\/s41392-024-01891-4.","journal-title":"Sig Transduct Target Ther"},{"key":"2653_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva M, O\u2019Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10:170\u201381. https:\/\/doi.org\/10.1038\/nri2711.","journal-title":"Nat Rev Immunol"},{"key":"2653_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12967-015-0590-1","volume":"13","author":"G Musuraca","year":"2015","unstructured":"Musuraca G, De Matteis S, Napolitano R, Papayannidis C, Guadagnuolo V, Fabbri F, Cangini D, Ceccolini M, Giannini MB, Lucchesi A, Ronconi S, Mariotti P, Savini P, Tani M, Fattori PP, Guidoboni M, Martinelli G, Zoli W, Amadori D, Carloni S. IL-17\/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia. J Transl Med. 2015;13:229. https:\/\/doi.org\/10.1186\/s12967-015-0590-1.","journal-title":"J Transl Med"},{"key":"2653_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41375-021-01375-2","volume":"36","author":"Y Xu","year":"2022","unstructured":"Xu Y, Mou J, Wang Y, Zhou W, Rao Q, Xing H, Tian Z, Tang K, Wang M, Wang J. Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway. Leukemia. 2022;36:403\u201315. https:\/\/doi.org\/10.1038\/s41375-021-01375-2.","journal-title":"Leukemia"},{"key":"2653_CR25","doi-asserted-by":"publisher","first-page":"1000996","DOI":"10.3389\/fimmu.2022.1000996","volume":"13","author":"M Luciano","year":"2022","unstructured":"Luciano M, Krenn PW, Horejs-Hoeck J. The cytokine network in acute myeloid leukemia. Front Immunol. 2022;13:1000996. https:\/\/doi.org\/10.3389\/fimmu.2022.1000996.","journal-title":"Front Immunol"},{"key":"2653_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-065X.2007.00573.x","volume":"220","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira J-P, Delaloge S, Andr\u00e9 F, Tursz T, Kroemer G, Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev. 2007;220:47\u201359. https:\/\/doi.org\/10.1111\/j.1600-065X.2007.00573.x.","journal-title":"Immunol Rev"},{"key":"2653_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","volume":"454","author":"J Zhai","year":"2019","unstructured":"Zhai J, Shen J, Xie G, Wu J, He M, Gao L, Zhang Y, Yao X, Shen L. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2019.04.002.","journal-title":"Cancer Lett"},{"key":"2653_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cyto.2011.06.005","volume":"56","author":"Y Wang","year":"2011","unstructured":"Wang Y, Qu Y, Niu XL, Sun WJ, Zhang XL, Li LZ. Autocrine production of interleukin-8 confers cisplatin and Paclitaxel resistance in ovarian cancer cells. Cytokine. 2011;56:365\u201375. https:\/\/doi.org\/10.1016\/j.cyto.2011.06.005.","journal-title":"Cytokine"},{"key":"2653_CR29","doi-asserted-by":"publisher","first-page":"107692","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther. 2021;219:107692. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107692.","journal-title":"Pharmacol Ther"},{"key":"2653_CR30","doi-asserted-by":"crossref","unstructured":"Ostrand-Rosenberg S, Fenselau C. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. J Immunol. 2018;200:422\u201331.","DOI":"10.4049\/jimmunol.1701019"},{"key":"2653_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12967-016-0894-9","volume":"14","author":"L Bi","year":"2016","unstructured":"Bi L, Wu J, Ye A, Wu J, Yu K, Zhang S, Han Y. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to Daunorubicin through activation of Akt signaling. J Transl Med. 2016;14:132. https:\/\/doi.org\/10.1186\/s12967-016-0894-9.","journal-title":"J Transl Med"},{"key":"2653_CR32","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1158\/1078-0432.CCR-19-0114","volume":"25","author":"NJ Llosa","year":"2019","unstructured":"Llosa NJ, Luber B, Tam AJ, Smith KN, Siegel N, Awan AH, Fan H, Oke T, Zhang J, Domingue J, Engle EL, Roberts CA, Bartlett BR, Aulakh LK, Thompson ED, Taube JM, Durham JN, Sears CL, Le DT, Diaz LA, Pardoll DM, Wang H, Anders RA, Housseau F. Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors. Clin Cancer Res. 2019;25:5250\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0114.","journal-title":"Clin Cancer Res"},{"key":"2653_CR33","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1111\/cas.14174","volume":"110","author":"A Aotsuka","year":"2019","unstructured":"Aotsuka A, Matsumoto Y, Arimoto T, Kawata A, Ogishima J, Taguchi A, Tanikawa M, Sone K, Mori-Uchino M, Tsuruga T, Oda K, Kawana K, Osuga Y, Fujii T. Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma. Cancer Sci. 2019;110:3068\u201378. https:\/\/doi.org\/10.1111\/cas.14174.","journal-title":"Cancer Sci"},{"key":"2653_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","volume":"407","author":"J Liu","year":"2011","unstructured":"Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, Lin Z, Zhu B. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011;407:348\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2011.03.021.","journal-title":"Biochem Biophys Res Commun"},{"key":"2653_CR35","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/onc.2013.268","volume":"33","author":"C-K Huang","year":"2014","unstructured":"Huang C-K, Yang C-Y, Jeng Y-M, Chen C-L, Wu H-H, Chang Y-C, Ma C, Kuo W-H, Chang K-J, Shew J-Y, Lee W-H. Autocrine\/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-\u03baB-mediated antiapoptotic pathway. Oncogene. 2014;33:2968\u201377. https:\/\/doi.org\/10.1038\/onc.2013.268.","journal-title":"Oncogene"},{"key":"2653_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3892\/ol.2018.9645","volume":"17","author":"G Sui","year":"2019","unstructured":"Sui G, Qiu Y, Yu H, Kong Q, Zhen B. Interleukin-17 promotes the development of cisplatin resistance in colorectal cancer. Oncol Lett. 2019;17:944\u201350. https:\/\/doi.org\/10.3892\/ol.2018.9645.","journal-title":"Oncol Lett"},{"key":"2653_CR37","doi-asserted-by":"publisher","first-page":"188758","DOI":"10.1016\/j.bbcan.2022.188758","volume":"1877","author":"S Li","year":"2022","unstructured":"Li S, Na R, Li X, Zhang Y, Zheng T. Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188758. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188758.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2653_CR38","doi-asserted-by":"crossref","unstructured":"Cui L, Fu J, Pang JC-S, Qiu Z-K, Liu X-M, ChenF-R, et al. Overexpression of IL-7 enhances cisplatin resistance in glioma. Cancer Biol Ther. 2012;13:496\u2013503.","DOI":"10.4161\/cbt.19592"},{"key":"2653_CR39","doi-asserted-by":"crossref","unstructured":"Tremblay CS, Saw J, Boyle JA, Haigh K, LitalienV, McCalmont H, et al. STAT5 activation promotes progression and chemotherapy resistance inearly T-cell precursor acute lymphoblastic leukemia. Blood. 2023;142:274\u201389.","DOI":"10.1182\/blood.2022016322"},{"key":"2653_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cellsig.2016.12.003","volume":"30","author":"D Cerezo","year":"2017","unstructured":"Cerezo D, Ruiz-Alcaraz AJ, Lencina-Guardiola M, C\u00e1novas M, Garc\u00eda-Pe\u00f1arrubia P, Mart\u00ednez-L\u00f3pez I. Mart\u00edn-Orozco, attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival. Cell Signal. 2017;30:162\u201370. https:\/\/doi.org\/10.1016\/j.cellsig.2016.12.003.","journal-title":"Cell Signal"},{"key":"2653_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.007","volume":"251","author":"A Brozovic","year":"2007","unstructured":"Brozovic A, Osmak M. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett. 2007;251:1\u201316. https:\/\/doi.org\/10.1016\/j.canlet.2006.10.007.","journal-title":"Cancer Lett"},{"key":"2653_CR42","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.5858\/133.11.1850","volume":"133","author":"Y Feng","year":"2009","unstructured":"Feng Y, Wen J, Chang C-CJ. p38 Mitogen-activated protein kinase and hematologic malignancies. Arch Pathol Lab Med. 2009;133:1850\u20136. https:\/\/doi.org\/10.5858\/133.11.1850.","journal-title":"Arch Pathol Lab Med"},{"key":"2653_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429:403\u201317. https:\/\/doi.org\/10.1042\/BJ20100323.","journal-title":"Biochem J"},{"key":"2653_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41417-023-00622-1","volume":"30","author":"T Phan","year":"2023","unstructured":"Phan T, Zhang XH, Rosen S, Melstrom LG. P38 kinase in Gastrointestinal cancers. Cancer Gene Ther. 2023;30:1181\u20139. https:\/\/doi.org\/10.1038\/s41417-023-00622-1.","journal-title":"Cancer Gene Ther"},{"key":"2653_CR45","doi-asserted-by":"publisher","first-page":"e0267855","DOI":"10.1371\/journal.pone.0267855","volume":"17","author":"S Matou-Nasri","year":"2022","unstructured":"Matou-Nasri S, Najdi M, AlSaud NA, Alhaidan Y, Al-Eidi H, Alatar G, AlWadaani D, Trivilegio T, AlSubait A, AlTuwaijri A, Abudawood M, Almuzzaini B. Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on MiRNA profiling. PLoS ONE. 2022;17:e0267855. https:\/\/doi.org\/10.1371\/journal.pone.0267855.","journal-title":"PLoS ONE"},{"key":"2653_CR46","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-15-0173","volume":"75","author":"A Igea","year":"2015","unstructured":"Igea A, Nebreda AR. The stress kinase p38\u03b1 as a target for cancer therapy. Cancer Res. 2015;75:3997\u20134002. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0173.","journal-title":"Cancer Res"},{"key":"2653_CR47","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR. Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol. 2021;22:346\u201366. https:\/\/doi.org\/10.1038\/s41580-020-00322-w.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2653_CR48","doi-asserted-by":"crossref","unstructured":"Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9:176.","DOI":"10.1038\/s41392-024-01868-3"},{"key":"2653_CR49","doi-asserted-by":"crossref","unstructured":"Khan SU, Fatima K, Aisha S, Malik F. Unveiling the mechanisms and challenges of cancer drug resistance. Cell Communication and Signaling. 2024;22:109.","DOI":"10.1186\/s12964-023-01302-1"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02653-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:23:50Z","timestamp":1772796230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2653"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02653-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}